JP2023527358A5 - - Google Patents
Info
- Publication number
- JP2023527358A5 JP2023527358A5 JP2022572568A JP2022572568A JP2023527358A5 JP 2023527358 A5 JP2023527358 A5 JP 2023527358A5 JP 2022572568 A JP2022572568 A JP 2022572568A JP 2022572568 A JP2022572568 A JP 2022572568A JP 2023527358 A5 JP2023527358 A5 JP 2023527358A5
- Authority
- JP
- Japan
- Prior art keywords
- pulmonary fibrosis
- pharmaceutical composition
- salt
- formula
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020901743 | 2020-05-28 | ||
| AU2020901743A AU2020901743A0 (en) | 2020-05-28 | Methods of treating pulmonary fibrosis | |
| PCT/AU2021/050457 WO2021237273A1 (en) | 2020-05-28 | 2021-05-17 | Methods of treating pulmonary fibrosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023527358A JP2023527358A (ja) | 2023-06-28 |
| JP2023527358A5 true JP2023527358A5 (https=) | 2024-05-14 |
| JP7745571B2 JP7745571B2 (ja) | 2025-09-29 |
Family
ID=78745664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022572568A Active JP7745571B2 (ja) | 2020-05-28 | 2021-05-17 | 肺線維症を処置する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230190746A1 (https=) |
| EP (1) | EP4157278A4 (https=) |
| JP (1) | JP7745571B2 (https=) |
| KR (1) | KR20230017843A (https=) |
| CN (1) | CN115867281A (https=) |
| AU (1) | AU2021279205B2 (https=) |
| CA (1) | CA3177652A1 (https=) |
| NZ (1) | NZ793855A (https=) |
| WO (1) | WO2021237273A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3001119T3 (es) | 2019-03-28 | 2025-03-04 | Amplia Therapeutics Ltd | Una sal y forma cristalina de un inhibidor de FAK |
| WO2023139154A1 (en) * | 2022-01-19 | 2023-07-27 | Nordic Bioscience A/S | A method for detecting covid-19 in a patient |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9174946B2 (en) * | 2011-02-17 | 2015-11-03 | Cancer Therapeutics Crc Pty Ltd | Selective FAK inhibitors |
| WO2014027199A1 (en) * | 2012-08-14 | 2014-02-20 | Cancer Therapeutics Crc Pty Ltd | Fak and flt3 inhibitors |
| ES3001119T3 (es) * | 2019-03-28 | 2025-03-04 | Amplia Therapeutics Ltd | Una sal y forma cristalina de un inhibidor de FAK |
-
2021
- 2021-05-17 WO PCT/AU2021/050457 patent/WO2021237273A1/en not_active Ceased
- 2021-05-17 CN CN202180038818.0A patent/CN115867281A/zh active Pending
- 2021-05-17 JP JP2022572568A patent/JP7745571B2/ja active Active
- 2021-05-17 EP EP21813794.1A patent/EP4157278A4/en active Pending
- 2021-05-17 AU AU2021279205A patent/AU2021279205B2/en active Active
- 2021-05-17 KR KR1020227045766A patent/KR20230017843A/ko active Pending
- 2021-05-17 CA CA3177652A patent/CA3177652A1/en active Pending
- 2021-05-17 US US17/926,114 patent/US20230190746A1/en active Pending
- 2021-05-17 NZ NZ793855A patent/NZ793855A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540183A5 (https=) | ||
| MX2023001756A (es) | Peptidos funcionalizados como agentes antivirales. | |
| JP2023002662A5 (https=) | ||
| JP2010532373A5 (https=) | ||
| JP2010532372A5 (https=) | ||
| JP2015528471A5 (https=) | ||
| JP2017531038A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2015508749A5 (https=) | ||
| IL314873A (en) | Compositions and methods for treating disorders ameliorated by muscarnic receptor activation | |
| JP2008521827A5 (https=) | ||
| JP2023527358A5 (https=) | ||
| PH12021552930A1 (en) | 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same | |
| JP2020512337A5 (https=) | ||
| JP2019517587A5 (https=) | ||
| JP2014513123A5 (https=) | ||
| JP2021152008A5 (https=) | ||
| CN115803328A (zh) | 哌嗪-2,3-二酮衍生物及其在医药上的应用 | |
| JP2016514141A5 (https=) | ||
| JP2010527985A5 (https=) | ||
| JP2019533660A5 (https=) | ||
| JPWO2023195530A5 (https=) | ||
| JP2024544538A5 (https=) | ||
| JP2022551691A5 (https=) | ||
| JP2009511450A5 (https=) |